W
WAVEMAN · COMPANY
PSNL · Personalis, Inc.
> Ask across nine datasets ⌘K
LIVE
TEAM-0.32% 13F +439META+3.01% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET+4.32% 13F +710MSTR+17.56% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475TEAM-0.32% 13F +439META+3.01% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET+4.32% 13F +710MSTR+17.56% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475
← ALL COMPANIES

PSNL

Personalis, Inc.
HEALTHCARE SERVICES · SERVICES-MEDICAL LABORATORIES · CIK 0001527753
FORM 144 · 5☆ WATCH
INSIDER NET · 180D
-$7.1M
open-market buys minus sells, Form 4 codes P and S
INSIDER BUYERS · 180D
0
CONGRESS BUYERS · 1Y
0
FUNDS ADDED · QTR
112
13F, latest reported quarter
REVENUE GROWTH
-17.7%
XBRL, annual
NET MARGIN
-116.7%
CONVERSIONS · 180D
10
codes C/M, not in net · $1.9M priced
SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST
INSIDERS
net -$7.1M over 180 days
-$5.1M over 90 days
below 66% of Healthcare Services
CONGRESS
no member of Congress has reported trading it
FUNDS
112 funds added or opened last quarter
below 54% of Healthcare Services
REVENUE
-17.7% year over year
below 88% of Healthcare Services
MARGIN
-116.7% net margin
below 94% of Healthcare Services
BUYBACKS
no share repurchases reported
SHORT
no short interest reported
THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET
Insiders are net sellers: -$7.1M across 3 people in 180 days.
112 funds added or opened positions in the latest 13F quarter, of 161 holders.
The year, with the filings on it
Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail
TOTAL 12M RETURN +247.8%
+247.8%12M
+0%+94%+188%+282%2025-092025-102025-122026-032026-052026-072026-09 2026-07-15 · Chen Richard sold $1.5M2026-07-09 · Hall Christopher M sold $1.5M2026-06-26 · Hall Christopher M sold $1.3M2025-11-25 · Tachibana Aaron sold $1.1M2026-05-29 · Hall Christopher M sold $882.6K2026-06-26 · Tachibana Aaron sold $675.5K2025-11-18 · Tempus AI, Inc. bought $496.6K2026-06-04 · Tachibana Aaron sold $480.4K2026-05-29 · Tachibana Aaron sold $449.3K2025-11-03 · Hall Christopher M sold $266.2K2025-12-22 · Tempus AI, Inc. bought $250.0K2025-11-24 · Tempus AI, Inc. bought $249.0K2025-11-19 · Tempus AI, Inc. bought $248.8K2025-11-20 · Tempus AI, Inc. bought $248.8K2025-12-17 · Tempus AI, Inc. bought $248.8K2025-12-19 · Tempus AI, Inc. bought $248.7K2025-12-18 · Tempus AI, Inc. bought $248.6K2026-05-28 · Hall Christopher M sold $219.4K2025-11-21 · Tempus AI, Inc. bought $161.7K2025-11-25 · Tempus AI, Inc. bought $152.8K2025-11-25 · Tempus AI, Inc. bought $97.9K2025-11-21 · Tempus AI, Inc. bought $87.5K2026-06-29 · Tachibana Aaron sold $69.7K2026-01-22 · Tachibana Aaron sold $13.8K2026-07-15 · RICHARD CHEN filed to sell $1.5M2026-07-09 · Chris Hall filed to sell $1.4M2026-06-29 · AARON TACHIBANA filed to sell $64.9K2026-06-26 · Chris Hall filed to sell $1.3M2026-06-26 · AARON TACHIBANA filed to sell $645.3K
INSIDER BUYINSIDER SELLFORM 144
INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY
Live price
Daily candles from TradingView, on their licence — no filings are marked on this one
WHY THIS NAME IS ON THE DESK
Insiders have filed to sell — before selling.
The record shows a net $7.1M sold by insiders over 180 days, 112 funds added last quarter, $4.9M in planned Form 144 sales. Every figure is a federal filing, dated the day it became public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector from the SEC's own SIC classification
NTRACSTLPGNYHIMSWGSPRVATDOCAVAHGHADUSSERABDSX
Insider transactions
Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, Personalis, Inc. insiders sold a net $7.1M of stock across 126 Form 4 purchases and sales, with 0 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-05.

INSIDER
FILED
SHARES
VALUE
Chen Richard
President and CMO
SELL
2026-07-15
100,000.0
$1.5M
Hall Christopher M
Chief Executive Officer
SELL
2026-07-09
100,000.0
$1.5M
Tachibana Aaron
CFO AND COO
SELL
2026-06-29
4,982.0
$69.7K
Tachibana Aaron
CFO AND COO
SELL
2026-06-26
51,251.0
$675.5K
Hall Christopher M
Chief Executive Officer
SELL
2026-06-26
100,000.0
$1.3M
126 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 121 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders
13F · holdings as of the latest quarter funds have reported
Merck & Co., Inc.
14,044,943.0 sh
$188.2M
ARK Investment Management LLC
8,271,339.0 sh
$110.8M
BlackRock, Inc.
7,082,491.0 sh
$94.9M
LIGHTSPEED MANAGEMENT COMPANY, L.L.C.
6,101,850.0 sh
$81.8M
AMERIPRISE FINANCIAL INC
6,086,315.0 sh
$81.6M
SCHEDULE 13D/G
No 5%+ ownership filings
Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.
Planned sales · Form 144
Filed before the sale — intent, not a trade
RICHARD CHEN
FILED 2026-07-15
$1.5M
Chris Hall
FILED 2026-07-09
$1.4M
AARON TACHIBANA
FILED 2026-06-29
$64.9K
Chris Hall
FILED 2026-06-26
$1.3M
AARON TACHIBANA
FILED 2026-06-26
$645.3K
Fund concentration
N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show
ARK Genomic Revolution ETF
$44.3M POSITION · AS OF 2026-04-30
3.6%
AlphaCentric Life Sciences and Healthcare Fund
$407.9K POSITION · AS OF 2026-03-31
1.0%
NORTH SQUARE KENNEDY MICROCAP FUND
$187.0K POSITION · AS OF 2026-02-28
0.6%
Columbia Small Cap Growth Fund
$17.4M POSITION · AS OF 2026-02-28
0.5%
Columbia Variable Portfolio - Small Company Growth Fund
$911.3K POSITION · AS OF 2026-03-31
0.4%
BRUCE FUND
$1.5M POSITION · AS OF 2026-03-31
0.4%
SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK
Clinical pipeline
ClinicalTrials.gov · 1 registered trials, 1 still enrolling or running — a status change here is dated weeks before the press release
1
Not applicable
1 ACTIVE
TRIALS MATCHED TO THIS TICKER BY SPONSOR NAME · STUDIES RUN UNDER A SUBSIDIARY'S OWN NAME ARE NOT INCLUDED
Government contracts
USASpending.gov · total award ceilings over the contract's life, including awards won through subsidiaries — not annual revenue
Department Of Veterans Affairs
EO 14398 · 2026-09-30
$18.3M
FEDERAL AWARDS ≥ $25M IN THE LAST 90 DAYS · MATCHED VIA SAM.GOV PARENT REGISTRY
Fundamentals
Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all
2025-122024-122023-122022-12
REVENUE$69.6M$84.6M$73.5M$65.0M
OPERATING INCOME$-88.1M$-68.3M$-109.9M$-115.5M
NET INCOME$-81.3M$-81.3M$-108.3M$-113.3M
EPS (DILUTED)-0.91-1.37-2.25-2.48
OPERATING CASH FLOW$-74.9M$-45.1M$-56.3M$-70.2M
CASH$124.2M$91.4M$57.0M$89.1M
SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-05 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE
W WAVEMAN

Public filings, honestly analyzed. Official US government sources in one desk — every figure carries the date it was filed, and the methodology is published, backtest included.

SEC FORM 4FORM 13F 13D/GFORM 144XBRL STOCK ACTCONTRACTSFEC CFPBNRC
PRODUCT
DeskBacktester CompaniesAccount
SUPPORT
FAQMethodology Contact
LEGAL
TermsPrivacy Accessibility
© 2026 WAVEMAN · SOURCE: SEC EDGAR & OFFICIAL GOVERNMENT DATA · NOT INVESTMENT ADVICE · CHART BY TRADINGVIEW · UPDATED 2026-09-05 ALL SYSTEMS LIVE FOR MACHINES →